Turkey
Universal Radiotherapy is a Turkish startup established in 2018 with the backing of The Scientific and Technological Research Council of Turkey (TUBITAK) 1512 technoenterprise. The company's primary focus is the development of THE INNOVATIVE, IDEAL AND UNIVERSAL CONFORMITY INDEX SOFTWARE ALGORITHM FOR RADIOTHERAPY TREATMENT PLANNING. The solution, which received support from the Royal Academy of Engineering with Newton fund, is designed to be utilized in radiation oncology clinics for cancer treatment.
The product serves a dual purpose, serving as an evaluation tool for selecting the most suitable radiotherapy treatment plan and as an optimization tool for crafting the optimal radiotherapy treatment plan. A key highlight is the patent application of their product titled Innovative, Ideal and Universal Conformity Index Evaluation Tool and Method for Radiotherapy Treatment Planning, which is accessible via the online patent file tracking webpage of the Turkish Patent and Trademark Office using the application number (2019/14727).
Universal Radiotherapy operates within the realms of Digital Health, Health Care, Health and Wellness, and Healthtech and is headquartered in Turkey. Although specific details about the last investment and the involved investors are currently unavailable, the company's focus on innovative solutions in the critical field of cancer treatment makes it an intriguing prospect for potential investors seeking opportunities in the healthcare technology sector.
